MediWound MDWD
NASDAQ MDWD
$13.21 +0.10 (+0.72%)
At close: Aug 21, 2026 · 4:00 PM EDT

MediWound (MDWD) Gross Profit (2014 - 2026)

MediWound (MDWD) posted quarterly Gross Profit of $278000.0 for Q4 2025, down 69.21% year-over-year from $903000.0 in Q4 2024, and down 68.97% quarter-over-quarter from $896000.0 in Q3 2025.

MediWound (MDWD) Gross Profit (2014 - 2026) Analysis & Trends

MediWound's Gross Profit history runs 12 years deep, the most recent figure standing at $278000.0 for Q4 2025.

  • In Q4 2025, Gross Profit fell 69.21% year-over-year to $278000.0; the TTM figure through Dec 2025 stood at $3.3 million (up 23.54% YoY), while the FY2025 annual figure was $3.3 million, up 23.54% from the prior year.
  • Gross Profit for Q4 2025 stood at $278000.0, down from $896000.0 in the prior quarter.
  • The five-year high for Gross Profit was $8.2 million in Q4 2022, with the low at $278000.0 in Q4 2025.
  • The 5-year median for Gross Profit is $1.0 million (2022), against an average of $1.6 million.
  • The sharpest annual moves came in 2022 and 2023: Gross Profit surged 430.08% in 2022, then slumped 91.19% in 2023.
  • MediWound's Gross Profit stood at $1.5 million in 2021, then soared by 430.08% to $8.2 million in 2022, then plunged by 91.19% to $719000.0 in 2023, then increased by 25.59% to $903000.0 in 2024, then sank by 69.21% to $278000.0 in 2025.
  • Business Quant data shows MDWD's Gross Profit at $278000.0 in Q4 2025, $896000.0 in Q3 2025, and $1.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 MediWound 170.65 Mn 139.65 Mn 337,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 337,000.00
Jun 30, 2026 337,000.00
Dec 31, 2025 278,000.00
Dec 31, 2025 278,000.00
Sep 30, 2025 896,000.00
Sep 30, 2025 896,000.00
Jun 30, 2025 1.34 Mn
Jun 30, 2025 1.34 Mn
Mar 31, 2025 738,000.00
Mar 31, 2025 738,000.00
Dec 31, 2024 903,000.00
Dec 31, 2024 903,000.00
Sep 30, 2024 677,000.00
Sep 30, 2024 677,000.00
Jun 30, 2024 447,000.00
Jun 30, 2024 447,000.00
Mar 31, 2024 607,000.00
Mar 31, 2024 607,000.00
Dec 31, 2023 719,000.00
Dec 31, 2023 719,000.00